Mangrove Partners Anebulo Pharmaceuticals, Inc. Transaction History
Mangrove Partners
- $642 Million
- Q4 2024
A detailed history of Mangrove Partners transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Mangrove Partners holds 2,525,252 shares of ANEB stock, worth $3.69 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
2,525,252Holding current value
$3.69 Million% of portfolio
0.66%Shares
5 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$22.6 Million21.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$4.43 Million0.26% of portfolio
-
Lvw Advisors, LLC633KShares$923,4730.13% of portfolio
-
Morgan Stanley New York, NY420KShares$613,1910.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$230,2710.04% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $37.4M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...